WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
605198 Yantai North Andre Juice
- 38.38
- +0.61+1.62%
Market Closed Apr 3 15:00 CST
13.10BMarket Cap50.24P/E (TTM)
38.77High37.22Low14.27KlotVolume37.30Open37.77Pre Close54.34MTurnover0.57%Turnover Ratio50.24P/E (Static)341.20MShares49.2852wk High5.06P/B9.62BFloat Cap19.8252wk Low41.55Limit Up250.54MShs Float49.28Historical High33.99Limit Down4.10%Amplitude8.70Historical Low0.22Dividend TTM38.08Avg Price6.48KlotAsk0.57%Div YieldTTM100Lot Size7.48KlotBid
Yantai North Andre Juice Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 61.85%1.42B | 53.28%1.02B | 27.03%632.18M | 20.93%270.36M | -17.77%876.1M | -17.50%668.65M | -12.48%497.65M | -16.05%223.57M | 22.24%1.07B | 31.21%810.52M |
| Operating revenue | 61.85%1.42B | 53.28%1.02B | 27.03%632.18M | 20.93%270.36M | -17.77%876.1M | -17.50%668.65M | -12.48%497.65M | -16.05%223.57M | 22.24%1.07B | 31.21%810.52M |
| Other operating revenue | -16.49%6.32M | ---- | -15.79%2.57M | ---- | -38.54%7.57M | ---- | -18.59%3.05M | ---- | 27.33%12.31M | ---- |
| Total operating cost | 74.54%1.14B | 67.86%806.93M | 33.51%476.92M | 14.79%209.29M | -26.15%650.33M | -20.87%480.71M | -15.72%357.21M | -16.71%182.33M | 14.11%880.67M | 13.44%607.46M |
| Operating cost | 81.66%1.07B | 71.08%763.26M | 35.10%458.15M | 24.31%201.47M | -31.12%587.06M | -26.59%446.15M | -19.88%339.12M | -20.88%162.06M | 23.18%852.29M | 22.35%607.79M |
| Operating tax surcharges | 9.22%11.55M | -9.82%8.88M | -20.81%5.78M | -55.25%1.73M | -22.81%10.58M | -12.00%9.85M | -3.77%7.3M | 10.30%3.86M | 25.99%13.7M | 49.23%11.19M |
| Operating expense | 95.29%6.57M | 43.94%3.52M | 7.73%1.7M | -10.15%712.4K | -20.79%3.37M | -23.01%2.44M | -22.25%1.58M | -12.65%792.84K | 38.57%4.25M | 37.66%3.17M |
| Administration expense | 1.34%46.25M | 0.31%27.42M | -12.68%16.67M | -22.22%8.28M | 10.94%45.64M | -1.75%27.33M | 5.95%19.09M | 30.44%10.65M | -11.36%41.14M | 19.70%27.82M |
| Financial expense | -6.29%-14.38M | 79.12%-2.83M | 33.00%-8.48M | -219.30%-4.44M | 72.19%-13.53M | 72.85%-13.57M | 56.68%-12.66M | 489.69%3.72M | -788.98%-48.66M | -8,746.11%-49.98M |
| -Interest expense (Financial expense) | -96.99%37.03K | -98.40%18.52K | -97.98%18.52K | ---- | -9.18%1.23M | 9.63%1.16M | 2.61%914.95K | 45.84%701.86K | 153.41%1.35M | 5,615.79%1.06M |
| -Interest Income (Financial expense) | 51.75%-4.61M | 55.72%-3.64M | 53.54%-3.06M | 44.62%-1.8M | -43.69%-9.56M | -96.43%-8.23M | -173.58%-6.58M | -193.92%-3.24M | -59.08%-6.65M | -24.28%-4.19M |
| Research and development | 8.46%18.67M | -21.28%6.69M | 11.71%3.11M | 23.54%1.54M | -4.04%17.22M | 13.83%8.5M | 31.11%2.78M | 41.48%1.25M | 44.32%17.94M | 45.46%7.47M |
| Credit Impairment Loss | -239.47%-19.83M | -271.29%-16.65M | -385.80%-13.33M | ---- | 245.13%14.22M | 400.80%9.72M | 244.28%4.66M | ---- | -320.86%-9.8M | -194.73%-3.23M |
| Asset Impairment Loss | -1,531.93%-1.64M | -273.67%-192.52K | -273.67%-192.52K | ---- | 101.30%114.38K | 101.17%110.86K | 101.17%110.86K | ---- | -3,614.31%-8.8M | -2,545,874.17%-9.46M |
| Other net revenue | -155.89%-21.55M | -159.04%-19.95M | -176.24%-21.23M | -130.70%-7.72M | 208.64%38.55M | 257.63%33.8M | 304.25%27.85M | 267.27%25.14M | -79.36%12.49M | -240.09%-21.44M |
| Fair value change income | 76.03%-10.06M | 62.97%-10.99M | 36.44%-10.99M | -440.22%-9.41M | -77.51%-41.95M | 45.52%-29.67M | 53.18%-17.28M | 108.79%2.76M | -551.88%-23.63M | -1,336.21%-54.45M |
| Invest income | -85.02%9.5M | -85.05%7.64M | -91.97%3.04M | -92.80%1.61M | 38.83%63.37M | 14.04%51.08M | 7.56%37.82M | 42.23%22.31M | -8.08%45.65M | 210.62%44.79M |
| -Including: Investment income associates | ---- | ---- | ---- | ---- | ---- | ---- | --92.3K | ---- | ---- | ---- |
| Asset deal income | -1,635.80%-172.08K | -107,695.17%-357.3K | ---353.83K | ---5.76K | 336.24%11.2K | 98.58%-331.46 | ---- | ---- | -98.97%2.57K | -2,069.94%-23.28K |
| Other revenue | -76.58%651.86K | -76.77%593.7K | -76.81%588.72K | 36.82%90.35K | -69.33%2.78M | 174.56%2.56M | 217.27%2.54M | -91.11%66.03K | 662.24%9.07M | -26.58%930.79K |
| Operating profit | -1.14%261.32M | -10.70%198.03M | -20.36%134.02M | -19.61%53.36M | 34.01%264.32M | 22.09%221.75M | 28.30%168.29M | 105.09%66.37M | 23.01%197.25M | 86.26%181.62M |
| Add:Non operating Income | -66.44%3.29K | 32.05%1.74K | 17,407.03%1.74K | --43.7 | -60.19%9.8K | -96.05%1.32K | -99.96%9.96 | ---- | 230.87%24.62K | -64.95%33.42K |
| Less:Non operating expense | 146.81%129.68K | -74.61%8.83K | 155.50%8.28K | -78.10%710 | 5.50%52.54K | -85.98%34.77K | -98.63%3.24K | 17.04%3.24K | -89.32%49.8K | 175.52%248K |
| Total profit | -1.17%261.19M | -10.69%198.02M | -20.36%134.02M | -19.61%53.36M | 34.00%264.28M | 22.22%221.72M | 28.51%168.28M | 105.10%66.37M | 23.35%197.22M | 86.03%181.41M |
| Less:Income tax cost | -94.41%489.77K | -97.51%184.84K | -96.08%184.84K | ---- | 204.84%8.76M | 30,401.63%7.42M | 19,277.64%4.71M | --4.46M | 2,372.21%2.87M | 119.24%24.33K |
| Net profit | 2.03%260.7M | -7.68%197.83M | -18.18%133.83M | -13.82%53.36M | 31.47%255.52M | 18.15%214.29M | 24.93%163.57M | 91.33%61.91M | 21.46%194.35M | 85.77%181.38M |
| Net profit from continuing operation | 2.03%260.7M | -7.68%197.83M | -18.18%133.83M | -13.82%53.36M | 31.47%255.52M | 18.15%214.29M | 24.93%163.57M | 91.33%61.91M | 21.46%194.35M | 85.77%181.38M |
| Net profit of parent company owners | 2.03%260.7M | -7.68%197.83M | -18.18%133.83M | -13.82%53.36M | 31.47%255.52M | 18.15%214.29M | 24.93%163.57M | 91.33%61.91M | 21.46%194.35M | 85.77%181.38M |
| Earning per share | ||||||||||
| Basic earning per share | 5.63%0.75 | -5.00%0.57 | -17.39%0.38 | -11.76%0.15 | 31.48%0.71 | 19.05%0.6 | 27.78%0.46 | 88.89%0.17 | 25.58%0.54 | 90.19%0.504 |
| Diluted earning per share | 5.63%0.75 | -5.00%0.57 | -17.39%0.38 | -11.76%0.15 | 31.48%0.71 | 19.05%0.6 | 27.78%0.46 | 88.89%0.17 | 25.58%0.54 | 90.19%0.504 |
| Other composite income | ||||||||||
| Total composite income | 2.03%260.7M | -7.68%197.83M | -18.18%133.83M | -13.82%53.36M | 31.47%255.52M | 18.15%214.29M | 24.93%163.57M | 91.33%61.91M | 21.46%194.35M | 85.77%181.38M |
| Total composite income of parent company owners | 2.03%260.7M | -7.68%197.83M | -18.18%133.83M | -13.82%53.36M | 31.47%255.52M | 18.15%214.29M | 24.93%163.57M | 91.33%61.91M | --194.35M | 85.77%181.38M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.